| Twist, a novel oncogene, is upregulated in pancreatic cancer | pancreatic, |
| Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice. | pancreatic, |
| Together these findings suggest that silencing of TWIST1 in oncogene driver-dependent NSCLCs represents a novel and promising therapeutic strategy. | lung, |
| Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance. | bladder, |
| Twist1 gene may play a role as an oncogene during the tumorigenesis and development in bladder urothelial carcinoma. | bladder, |
| These studies identified harmine as a first-in-class TWIST1 inhibitor with marked anti-tumor activity in oncogene-driven non-small cell lung cancer (NSCLC)including EGFR mutant, KRAS mutant and MET altered NSCLC | lung, |
| These new findings suggest an oncogenic role for concomitant expression of MAML1 and TWIST1 genes in head and neck squamous cell carcinoma invasion and metastasis | HNSC, |
| High levels of lncRNA HULC (Highly Upregulated in Liver Cancer) correlate with Ewing sarcoma (ES) aggressiveness, whereas HULC depletion reduces ES cell growth. HULC promotes the expression of TWIST1 oncogene by sponging miR-186. High levels of miR-186 and low levels of TWIST1 correlate with better prognosis in ES patients. Results disclose a novel oncogenic regulatory circuit mediated by HULC lncRNA. | sarcoma,liver, |
| Twist is a potential oncogene that inhibits apoptosis. | None |
| Twist1 and Twist2 antagonize the ARF/p53 pathway. This is the first report suggesting a role for Twist genes as oncogenes | None |
| The tyrosine kinase receptor EphA4 and the potentially oncogenic transcription factor Twist were highly and selectively expressed in T cells of patients with Sezary Syndrome. | None |
| The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. | None |
| Mechanism of transcriptional activation by the proto-oncogene Twist1. | None |
| analysis of transcriptional activation by the proto-oncogene Twist1 | None |
| STAT3, Twist, and AKT2 form a functional signaling axis to regulate pivotal oncogenic properties of cancer cells | None |
| The proto-oncogene TWIST1 is regulated by microRNAs. | None |
| The proto-oncogene TWIST1 is regulated by microRNAs. | None |
| At the molecular level, we demonstrated that HDAC5 promoted mRNA expression of twist 1, which has been reported as an oncogene | None |